Form 4 Tango Therapeutics Inc For: 5 October
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tango Therapeutics Inc (TNGX)
Tango Therapeutics Inc stock price live, this page displays NASDAQ TNGX stock exchange data. View the TNGX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tango Therapeutics Inc real time stock price chart below.
What Is the Tango Therapeutics Inc Stock Price Today?
The Tango Therapeutics Inc stock price today is 23.81.
What Is the Stock Symbol for Tango Therapeutics Inc?
The stock symbol for Tango Therapeutics Inc is "TNGX."
What Stock Exchange Does Tango Therapeutics Inc Trade On?
Tango Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tango Therapeutics Inc a Good Stock to Buy?
Determining whether Tango Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TNGX quote. (ISIN: US87583X1090)
What Is the Tango Therapeutics Inc Stock Price Today?
The Tango Therapeutics Inc stock price today is 23.81.
What Is the Stock Symbol for Tango Therapeutics Inc?
The stock symbol for Tango Therapeutics Inc is "TNGX."
What Stock Exchange Does Tango Therapeutics Inc Trade On?
Tango Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tango Therapeutics Inc a Good Stock to Buy?
Determining whether Tango Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TNGX quote. (ISIN: US87583X1090)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.44
24.12
52 wk Range
6.69
34.39
TNGX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.4424.12
52 wk Range
6.6934.39
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TNGX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
45.18
Upside
+89.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
7 analysts have revised their earnings downwards for the upcoming period
Form 4 Tango Therapeutics Inc For: 24 September- Investing.com
- Form 4 Tango Therapeutics Inc For: 5 October
- Investing.com
- Form 4 Tango Therapeutics Inc For: 24 September
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 45.18
(+89.76% Upside)
Tango Therapeutics Inc SWOT Analysis
Innovative Pipeline | Tango Therapeutics' PRMT5 inhibitor trials for pancreatic and lung cancers could revolutionize treatment, with expansion data expected in late 2025 |
Financial Outlook | Despite projected losses, Tango extends cash runway to Q1 2027, demonstrating efficient capital allocation and maintaining a healthy current ratio of 6.26 |
Market Positioning | Explore Tango's unique position in targeted cancer therapies, with recent 53% price return and analyst price target of $13, despite being 61% below 52-week high |
Growth Potential | Delve into Tango's opportunities in precision oncology, including expansion into multiple cancer indications and potential partnerships with pharmaceutical giants |
Earnings
Latest Release
Aug 11, 2026
EPS / Forecast
-0.37 / -0.32
Revenue / Forecast
-- / 1.56M
Compare TNGX to Peers and Sector
Metrics to compare | TNGX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTNGXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −32.4x | −6.8x | −0.3x | |
PEG Ratio | −1.05 | 0.01 | 0.00 | |
Price/Book | 3.9x | 1.8x | 2.6x | |
Price / LTM Sales | 74.6x | 30.6x | 3.0x | |
Upside (Analyst Target) | 89.8% | 111.0% | 61.4% | |
Fair Value Upside | Unlock | 2.9% | 7.4% | Unlock |
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Tango Therapeutics (TNGX) Stock Price Today?
The Tango Therapeutics stock price today is 23.81 USD.
What Stock Exchange Does Tango Therapeutics Trade On?
Tango Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tango Therapeutics?
The stock symbol for Tango Therapeutics is "TNGX."
What Is the Tango Therapeutics Market Cap?
As of today, Tango Therapeutics market cap is 3.81B USD.
What Is Tango Therapeutics's Earnings Per Share (TTM)?
The Tango Therapeutics EPS (TTM) is -0.91.
When Is the Next Tango Therapeutics Earnings Date?
Tango Therapeutics will release its next earnings report on Nov 10, 2026.
From a Technical Analysis Perspective, Is TNGX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Tango Therapeutics Stock Split?
Tango Therapeutics has split 0 times.
How Many Employees Does Tango Therapeutics Have?
Tango Therapeutics has 137 employees.
What is the current trading status of Tango Therapeutics (TNGX)?
As of Oct 10, 2026, Tango Therapeutics (TNGX) is trading at a price of 23.81 USD, with a previous close of 23.81 USD. The stock has fluctuated within a day range of 22.44 USD to 24.12 USD, while its 52-week range spans from 6.69 USD to 34.39 USD.
What Is Tango Therapeutics (TNGX) Price Target According to Analysts?
The average 12-month price target for Tango Therapeutics is 45.18 USD, with a high estimate of 69 USD and a low estimate of 24 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +89.76% Upside potential.
What Is the TNGX Premarket Price?
TNGX's last pre-market stock price is 22.60 USD. The pre-market share volume is 250.00, and the stock has decreased by 0.03, or 0.13%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.